Recurrent COVID-19 in a Patient With Ulcerative Colitis on Vedolizumab Therapy.

Crouwel, Femke; Waaijenberg-Warmenhoven, Petra; Buiter, Hans J C; de Boer, Nanne K

Crouwel, Femke; Waaijenberg-Warmenhoven, Petra; Buiter, Hans J C; de Boer, Nanne K.

Crouwel F; Department of Gastroenterology and Hepatology, AGEM Research Institute, Amsterdam University Medical Centre, Vrije Universiteit Amsterdam, Amsterdam, the Netherlands.
Waaijenberg-Warmenhoven P; Department of Gastroenterology and Hepatology, Amsterdam University Medical Centre, Vrije Universiteit Amsterdam, Amsterdam, the Netherlands.
Buiter HJC; Department of Clinical Pharmacology and Pharmacy, Amsterdam University Medical Centre, Vrije Universiteit Amsterdam, Amsterdam, the Netherlands.
de Boer NK; Department of Gastroenterology and Hepatology, AGEM Research Institute, Amsterdam University Medical Centre, Vrije Universiteit Amsterdam, Amsterdam, the Netherlands.

J Crohns Colitis ; 15(7): 1244-1245, 2021 Jul 05.

Article in English | MEDLINE | ID: covidwho-990607

Subject(s)

Antibodies, Monoclonal, Humanized/therapeutic use; COVID-19/diagnosis; COVID-19/etiology; Colitis, Ulcerative/therapy; Gastrointestinal Agents/therapeutic use; Reinfection/etiology; Adult; Colitis, Ulcerative/complications; Female; Humans; Reinfection/diagnosis

Keywords

COVID-19; Ulcerative colitis; vedolizumab

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Gastrointestinal Agents / Colitis, Ulcerative / Antibodies, Monoclonal, Humanized / Reinfection / COVID-19 Type of study: Case report / Diagnostic study Topics: Long Covid Limits: Adult / Female / Humans Language: English Journal: J Crohns Colitis Journal subject: Gastroenterology Year: 2021 Document Type: Article Affiliation country: Ecco-jcc

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google